Alector

ALECNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$224.430 M

$2.01 +4.14%

Close of 22 Sept 2026

Revenue

$21.0M

#2972 by revenue

Earnings

-$143.0M

Loss-making

Shares outstanding

111,656,919

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#92Protalix BioTherapeuticsPLX$228.8M
#93Cardiol TherapeuticsCRDL$228.0M
#94AlectorALEC$224.4M
#95Compass TherapeuticsCMPX$223.3M
#96Protara TherapeuticsTARA$217.5M

What if Alector were worth as much as…

Open the what-if tool →

Gold $30.2T

$270,775.60

Per share 134,714× higher

Bitcoin $1.74T

$15,598.27

Per share 7,760× higher

Nvidia $5.52T

$49,399.24

Per share 24,577× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Alector are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.